あすか製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証1部 | 医薬品 | 4514/E00929 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2014/10/10 | 日証協 | 171,788株 | -2.5% | 39,183株 | +53.51% | 150,163株 | -3.72% | 9,764株 | -45.21% |
2014/10/03 | 日証協 | 176,190株 | -3.68% | 25,524株 | +23.3% | 155,960株 | -6.7% | 17,821株 | -22.36% |
2014/09/26 | 日証協 | 182,925株 | -1.63% | 20,700株 | +107% | 167,160株 | -6.23% | 22,953株 | +206.04% |
2014/09/19 | 日証協 | 185,965株 | -11.64% | 10,000株 | -45.65% | 178,260株 | -12.04% | 7,500株 | +293.29% |
2014/09/12 | 日証協 | 210,465株 | -7.71% | 18,400株 | -72.08% | 202,653株 | -8.66% | 1,907株 | -93.56% |
2014/09/05 | 日証協 | 228,040株 | -1.08% | 65,900株 | +46.12% | 221,860株 | -0.26% | 29,600株 | +9.98% |
2014/08/29 | 日証協 | 230,540株 | -14.34% | 45,100株 | +159.61% | 222,447株 | -12.85% | 26,913株 | +60.2% |
2014/08/22 | 日証協 | 269,140株 | -5.53% | 17,372株 | -59.79% | 255,247株 | -0.46% | 16,800株 | +39.73% |
2014/08/15 | 日証協 | 284,908株 | +2.15% | 43,200株 | -64.83% | 256,424株 | +1.42% | 12,023株 | +21.44% |
2014/08/08 | 日証協 | 278,908株 | +0.65% | 122,816株 | +233.67% | 252,824株 | -1.79% | 9,900株 | +209.38% |
2014/08/01 | 日証協 | 277,108株 | -4.58% | 36,808株 | -4.89% | 257,424株 | -5.12% | 3,200株 | +45.45% |
2014/07/25 | 日証協 | 290,408株 | -7.52% | 38,700株 | -68.97% | 271,324株 | -6.58% | 2,200株 | -93.49% |
2014/07/18 | 日証協 | 314,008株 | -5.31% | 124,700株 | -1.73% | 290,424株 | -11.35% | 33,800株 | -65.55% |
2014/07/11 | 日証協 | 331,608株 | -3.13% | 126,900株 | +92.56% | 327,624株 | +10.53% | 98,100株 | +207.52% |
2014/07/04 | 日証協 | 342,308株 | +6.44% | 65,900株 | -57.43% | 296,424株 | +0.88% | 31,900株 | +262.5% |
2014/06/27 | 日証協 | 321,608株 | -3.59% | 154,808株 | -72.82% | 293,824株 | -14.12% | 8,800株 | -89.91% |
2014/06/20 | 日証協 | 333,578株 | +11.52% | 569,530株 | +117.75% | 342,116株 | +11.24% | 87,208株 | -37.8% |
2014/06/13 | 日証協 | 299,120株 | -1.11% | 261,548株 | +52.53% | 307,558株 | -11.24% | 140,200株 | +17.13% |
2014/06/06 | 日証協 | 302,478株 | -21.88% | 171,475株 | -64.37% | 346,516株 | -15.72% | 119,700株 | -64.6% |
※株式分割は考慮していませんのでご注意ください。
Page Top